Cyclosporine News and Research

RSS
Cyclosporine is a drug used to help reduce the risk of rejection of organ and bone marrow transplants by the body. It is also used in clinical trials to make cancer cells more sensitive to anticancer drugs.
Atopic dermatitis found to be highly prevalent among adults in the U.S.

Atopic dermatitis found to be highly prevalent among adults in the U.S.

Sun Pharma receives U.S. FDA approval for CEQUA to treat patients with dry eye disease

Sun Pharma receives U.S. FDA approval for CEQUA to treat patients with dry eye disease

CHOP experts identify new autoimmune disorder along with personalized treatment for young patient

CHOP experts identify new autoimmune disorder along with personalized treatment for young patient

Aurinia’s Phase 2 trial evaluates voclosporin ophthalmic solution for treating dry eye syndrome

Aurinia’s Phase 2 trial evaluates voclosporin ophthalmic solution for treating dry eye syndrome

Researchers uncover racial differences in debilitating itchy skin condition

Researchers uncover racial differences in debilitating itchy skin condition

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

Herbal products may affect properties of prescription drugs and lead to dangerous side effects

Herbal products may affect properties of prescription drugs and lead to dangerous side effects

Component of fire ant venom shows promise as a psoriasis treatment

Component of fire ant venom shows promise as a psoriasis treatment

Immune booster could improve effectiveness of vaccines and cancer immunotherapy

Immune booster could improve effectiveness of vaccines and cancer immunotherapy

Penn State dermatologist clarifies common myths about psoriasis

Penn State dermatologist clarifies common myths about psoriasis

Psoriasis treatments may help improve cardiovascular symptoms by reducing skin inflammation

Psoriasis treatments may help improve cardiovascular symptoms by reducing skin inflammation

Breakthrough technique removes potentially harmful additives from common injectable drugs

Breakthrough technique removes potentially harmful additives from common injectable drugs

Many kidney transplant patients may benefit from lower-than-standard dose of CNIs

Many kidney transplant patients may benefit from lower-than-standard dose of CNIs

Allo-HSCT Non-Relapse Related Mortality Reduction Revealed

Allo-HSCT Non-Relapse Related Mortality Reduction Revealed

First patient enrolled in Phase 2 clinical trial of Immune's bertilimumab in Ulcerative Colitis

First patient enrolled in Phase 2 clinical trial of Immune's bertilimumab in Ulcerative Colitis

Study suggests combination of MMF and CNIs can protect against rare lymphoma

Study suggests combination of MMF and CNIs can protect against rare lymphoma

Researchers link organ transplant drug to rise in rare lymphoma

Researchers link organ transplant drug to rise in rare lymphoma

Immune submits Bertilimumab IND application to FDA for treatment of Bullous Pemphigoid

Immune submits Bertilimumab IND application to FDA for treatment of Bullous Pemphigoid

Immune Pharmaceuticals’ CEO establishes stock trading plan

Immune Pharmaceuticals’ CEO establishes stock trading plan

Cyclosporine drug does not improve outcomes in STEMI patients receiving PCI

Cyclosporine drug does not improve outcomes in STEMI patients receiving PCI